Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.75B |
| 2 |
NVIDIA
NVDA
|
+$1.34B |
| 3 |
Capital One
COF
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$1.01B |
| 5 |
Amazon
AMZN
|
+$813M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$1.09B |
| 2 |
Palantir
PLTR
|
+$777M |
| 3 |
Coca-Cola
KO
|
+$496M |
| 4 |
Qualcomm
QCOM
|
+$469M |
| 5 |
Applovin
APP
|
+$390M |
Sector Composition
| 1 | Technology | 32.48% |
| 2 | Financials | 14.03% |
| 3 | Consumer Discretionary | 10.52% |
| 4 | Healthcare | 9.35% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3776
Arqit Quantum
ARQQ
$405M
| $268K | ﹤0.01% |
+7,246
| New | +$268K |
|
3777
Clene
CLNN
$66.2M
| $267K | ﹤0.01% |
68,328
-642
| -0.9% | -$2.51K |
|
|
MSB
3778
Mesabi Trust
MSB
$410M
| $265K | ﹤0.01% |
+11,042
| New | +$265K |
|
3779
AN2 Therapeutics
ANTX
$32.5M
| $264K | ﹤0.01% |
249,351
-4,572
| -2% | -$4.85K |
|
3780
Celularity
CELU
$56.3M
| $264K | ﹤0.01% |
134,825
-1,216
| -0.9% | -$2.38K |
|
3781
Knightscope
KSCP
$55.5M
| $264K | ﹤0.01% |
53,372
+13,081
| +32% | +$64.6K |
|
|
CISO
3782
CISO Global
CISO
$36.1M
| $263K | ﹤0.01% |
228,690
+168,637
| +281% | +$194K |
|
3783
Precision Optics
POCI
$34.3M
| $263K | ﹤0.01% |
53,891
-151
| -0.3% | -$736 |
|
3784
Harte-Hanks
HHS
$27.2M
| $260K | ﹤0.01% |
65,405
-88
| -0.1% | -$350 |
|
3785
United-Guardian
UG
$38.8M
| $260K | ﹤0.01% |
32,604
-244
| -0.7% | -$1.94K |
|
3786
BTCS Inc
BTCS
$202M
| $259K | ﹤0.01% |
117,717
+3,172
| +3% | +$6.98K |
|
3787
Noodles & Co
NDLS
$30.9M
| $258K | ﹤0.01% |
362,037
-1,113
| -0.3% | -$794 |
|
3788
Grove Collaborative
GROV
$62.3M
| $258K | ﹤0.01% |
224,366
-535
| -0.2% | -$615 |
|
|
REFI
3789
Chicago Atlantic Real Estate Finance
REFI
$300M
| $257K | ﹤0.01% |
18,367
+1,446
| +9% | +$20.2K |
|
3790
Dyadic International
DYAI
$32.9M
| $257K | ﹤0.01% |
259,154
+732
| +0.3% | +$725 |
|
3791
WidePoint Corp
WYY
$51.4M
| $256K | ﹤0.01% |
74,949
+778
| +1% | +$2.66K |
|
3792
Cenntro
CENN
$27.3M
| $253K | ﹤0.01% |
326,486
-1,742
| -0.5% | -$1.35K |
|
3793
SEALSQ Corp
LAES
$355M
| $252K | ﹤0.01% |
62,449
+49,534
| +384% | +$200K |
|
|
GRRR
3794
Gorilla Technology Group
GRRR
$413M
| $251K | ﹤0.01% |
+12,639
| New | +$251K |
|
3795
Xilio Therapeutics
XLO
$36.3M
| $251K | ﹤0.01% |
369,660
-9,356
| -2% | -$6.36K |
|
3796
LGL Group
LGL
$35.7M
| $251K | ﹤0.01% |
32,941
+81
| +0.2% | +$617 |
|
|
MREO
3797
Mereo BioPharma
MREO
$285M
| $251K | ﹤0.01% |
92,534
+378
| +0.4% | +$1.02K |
|
3798
US Energy Corp
USEG
$37.8M
| $250K | ﹤0.01% |
178,241
+5,530
| +3% | +$7.74K |
|
3799
Flanigan's Enterprises
BDL
$57.6M
| $249K | ﹤0.01% |
+7,177
| New | +$249K |
|
|
CTOR
3800
Citius Oncology, Inc. Common Stock
CTOR
$144M
| $249K | ﹤0.01% |
57,297
+36,758
| +179% | +$160K |
|